高级检索
当前位置: 首页 > 详情页

Influence of cardiopulmonary exercise test on platelet function in patients with coronary artery diseases on antiplatelet therapy

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China [2]Chongqing Gen Hosp, Dept Cardiol, Chongqing 401147, Peoples R China [3]Beijing First Hosp Integrated Chinese & Western M, Cardiac Rehabil Ctr, Beijing 100026, Peoples R China [4]China Japan Friendship Hosp, Dept Cardiol, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Coronary artery diseases Exercise test Platelet function Cardiac rehabilitation

摘要:
Background: Cardiac rehabilitation reduces mortality and morbidity rate of patients with coronary artery diseases (CAD); however, acute exercise stimulation may also increase the thrombotic risk through platelet activation. Studies on the effects of cardiac rehabilitation on platelet function have been sparse. Methods: A total of 28 patients (24 men and 4 women; average age = 54.6 +/- 8 years old) with stable CAD were enrolled in this study and divided into Aspirin-treated (n =11; Aspirin group) and dual-antiplatelet-treated group (DAPT group; n =17). Symptom-limited cardiopulmonary exercise test (CPET) with a cycle ergometer was performed on all the patients. Before and after CPET, platelet function was evaluated using light transmission aggregometry and whole blood flow cytometry. Results: All patients completed the CPET without provoked cardiac events, and the mean value of peak oxygen uptake (Peak Vo(2)) was 19.3 +/- 3 ml/(kg min). Prior to CPET, platelet aggregation was significantly suppressed in DAPT group compared to Aspirin group (43.0 +/- 21.5 vs. 72.9 +/- 7.5,p < 0.001). CPET promoted platelet aggregation in Aspirin group (72.9 +/- 7.5 vs. 80.9 +/- 7.6, p= 0.005) and DAPT group (43.0 +/- 21.5 vs. 50.1 +/- 20.9, p= 0.010), and platelet count was increased in Aspirin (210.9 +/- 54.6 vs. 227.5 +/- 58.1, p= 0.001) and DAPT group (217.5 +/- 63.8 vs. 229.7 +/- 63.7, p= 0.001). However, the expression levels of CD62p and PAC-1 were not affected by CPET in both groups. Conclusion: Symptom-limited CPET enhanced platelet aggregation in patients with CAD despite treatment with antiplatelet, mainly via platelet count augmentation, but not through single platelet activation.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 心脏和心血管系统
JCR分区:
出版当年[2020]版:
Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China [2]Chongqing Gen Hosp, Dept Cardiol, Chongqing 401147, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)